Detalhe da pesquisa
1.
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.
Invest New Drugs
; 36(6): 1037-1043, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785570
2.
Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.
Br J Cancer
; 105(11): 1654-62, 2011 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045187
3.
Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies.
Ann Oncol
; 19(10): 1742-8, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18534963
4.
Treatment advances in non-Hodgkin's lymphoma.
Expert Opin Pharmacother
; 1(3): 451-66, 2000 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11249530
5.
Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma.
J Natl Cancer Inst
; 91(20): 1779-80, 1999 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-10528031
6.
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar.
Br J Cancer
; 93(1): 46-53, 2005 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-15942626
7.
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.
Ann Oncol
; 13(11): 1819-25, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12419757